Brighthouse Financial Announces Conference Call to Discuss First Quarter 2025 Results

CHARLOTTE, N.C.--(BUSINESS WIRE)-- Brighthouse Financial, Inc. (Brighthouse Financial) (Nasdaq: BHF) announced today that it plans to hold a conference call and audio webcast to discuss its financial results for the first quarter ended March 31, 2025, at 8:00 a.m. Eastern Time on Thursday, May 8, 2025. The call will follow the issuance of the Brighthouse Financial first quarter 2025 earnings release and financial supplement on Wednesday, May 7, 2025, after market close.

To listen to the audio webcast via the internet and to access the related presentation, please visit the Brighthouse Financial Investor Relations webpage at http://investor.brighthousefinancial.com. To join the conference call via telephone as a participant, please register in advance at https://register-conf.media-server.com/register/BI037295eefd1c4f5886dc75c173cc1412.

A replay of the conference call will be made available until Friday, May 23, 2025, on the Brighthouse Financial Investor Relations webpage at http://investor.brighthousefinancial.com.

About Brighthouse Financial, Inc.

Brighthouse Financial, Inc. (Brighthouse Financial) (Nasdaq: BHF) is on a mission to help people achieve financial security. As one of the largest providers of annuities and life insurance in the U.S.,1 we specialize in products designed to help people protect what they’ve earned and ensure it lasts. Learn more at brighthousefinancial.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250407322246/en/

FOR INVESTORS
Dana Amante
(980) 949-3073
[email protected]

FOR MEDIA
Deon Roberts
(980) 949-3071
[email protected]

Source: Brighthouse Financial, Inc.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• TPU-As-A-Service could boost Google’s 2028 profit by over 15%: Barclays
• Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) for the Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Adults and Pediatric Patients Aged 6 Years and Older